ICM
NOC icon

Invenomic Capital Management’s Northrop Grumman NOC Stock Holding History

Invenomic Capital Management’s Portfolio NOC Stock Details NOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,805
Closed -$656K – 140
2021
Q2 		$656K Sell
1,805
-318
-15% -$115K 0.16% 97
2021
Q1 		$687K Buy
+2,123
New +$640K 0.15% 95

Other funds holding NOC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's NOC Position: Q3 2021 in Review

Invenomic Capital Management sold out of Northrop Grumman (NOC) in Q3 2021, closing a stake of 1,805 shares — an estimated $656K sold.

Invenomic Capital Management first reported a position in NOC in Q1 2021 and held it in 2 quarters. The position peaked at $687K in Q1 2021. 1,198 funds tracked by Wall St. Rank hold NOC as of Q3 2021.

  • Invenomic Capital Management reported no remaining Northrop Grumman position as of Q3 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 1,805 Northrop Grumman shares in Q3 2021, an estimated $656K.
  • Invenomic Capital Management first reported a position in Northrop Grumman in Q1 2021 and held it in 2 quarters.
  • Invenomic Capital Management's Northrop Grumman position peaked at $687K in Q1 2021.
  • 1,198 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2021.

Based on Invenomic Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.